Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 808

1.

Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival.

Dos Santos MA, Pignon JP, Blanchard P, Lefeuvre D, Levy A, Touat M, Louvel G, Dhermain F, Soria JC, Deutsch E, Le Teuff G.

J Neurooncol. 2015 May 15. [Epub ahead of print]

PMID:
25975195
2.

Toxicity of concomitant cetuximab and radiotherapy with or without initial taxane-based induction chemotherapy in locally advanced head and neck cancer.

Levy A, De Felice F, Bellefqih S, Guigay J, Deutsch E, Nguyen F, Blanchard P, Tao Y.

Head Neck. 2015 May 13. doi: 10.1002/hed.24125. [Epub ahead of print]

PMID:
25974356
3.

Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer.

Mondini M, Nizard M, Tran T, Mauge L, Loi M, Clémenson C, Dugue D, Maroun P, Louvet E, Adam J, Badoual C, Helley D, Dransart E, Johannes L, Vozenin MC, Perfettini JL, Tartour E, Deutsch E.

Mol Cancer Ther. 2015 Apr 1. [Epub ahead of print]

PMID:
25833837
4.

Transition to Surgical Residency: A Multi-Institutional Study of Perceived Intern Preparedness and the Effect of a Formal Residency Preparatory Course in the Fourth Year of Medical School.

Minter RM, Amos KD, Bentz ML, Blair PG, Brandt C, D'Cunha J, Davis E, Delman KA, Deutsch ES, Divino C, Kingsley D, Klingensmith M, Meterissian S, Sachdeva AK, Terhune K, Termuhlen PM, Mullan PB.

Acad Med. 2015 Mar 17. [Epub ahead of print]

PMID:
25785673
5.

Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial.

Levy A, Azria D, Pignon JP, Delarochefordiere A, Martel-Lafay I, Rio E, Malka D, Conroy T, Miglianico L, Becouarn Y, Malekzadeh K, Leclercq J, Juzyna B, Ezra P, Lemanski C, Deutsch E.

Radiother Oncol. 2015 Mar;114(3):415-6. doi: 10.1016/j.radonc.2015.02.008. Epub 2015 Mar 11. No abstract available.

PMID:
25769380
6.

Development of data representation standards by the human proteome organization proteomics standards initiative.

Deutsch EW, Albar JP, Binz PA, Eisenacher M, Jones AR, Mayer G, Omenn GS, Orchard S, Vizcaíno JA, Hermjakob H.

J Am Med Inform Assoc. 2015 Feb 28. pii: ocv001. doi: 10.1093/jamia/ocv001. [Epub ahead of print] Review.

7.

Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer.

Deutsch E, Le Péchoux C, Faivre L, Rivera S, Tao Y, Pignon JP, Angokai M, Bahleda R, Deandreis D, Angevin E, Hennequin C, Besse B, Levy A, Soria JC.

Ann Oncol. 2015 Jun;26(6):1223-9. doi: 10.1093/annonc/mdv105. Epub 2015 Feb 20.

8.

Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines.

Fumagalli I, Dugue D, Bibault JE, Clémenson C, Vozenin MC, Mondini M, Deutsch E.

Onco Targets Ther. 2015 Feb 2;8:335-45. doi: 10.2147/OTT.S68235. eCollection 2015.

9.

Field size dependent mapping of medical linear accelerator radiation leakage.

Bezin JV, Veres A, Lefkopoulos D, Chavaudra J, Deutsch E, de Vathaire F, Diallo I.

Phys Med Biol. 2015 Mar 7;60(5):2103-6. doi: 10.1088/0031-9155/60/5/2103.

PMID:
25675153
10.

Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration.

Arshad A, Deutsch E, Vozenin MC.

PLoS One. 2015 Jan 30;10(1):e0115447. doi: 10.1371/journal.pone.0115447. eCollection 2015.

11.

Trans-Proteomic Pipeline, a standardized data processing pipeline for large-scale reproducible proteomics informatics.

Deutsch EW, Mendoza L, Shteynberg D, Slagel J, Sun Z, Moritz RL.

Proteomics Clin Appl. 2015 Jan 29. doi: 10.1002/prca.201400164. [Epub ahead of print]

PMID:
25631240
12.

[Communication in the context of phase I clinical trials in oncology: implementation and evaluation of training programs].

Rouby P, Hollebecque A, Bahleda R, Deutsch E, Gomez-Rocca C, Angevin E, de La Motte Rouge T, Soria JC, Dauchy S.

Bull Cancer. 2015 Feb;102(2):174-81. doi: 10.1016/j.bulcan.2014.12.013. Epub 2015 Jan 15. French.

PMID:
25609484
13.

Implementation of the global risk analysis in pulsed-dose rate brachytherapy: Methods and results.

Mazeron R, Aguini N, Rivin Del Campo E, Dumas I, Gensse MC, Brusadin G, Lefkopoulos D, Deutsch E, Haie-Meder C.

Cancer Radiother. 2015 Apr;19(2):89-97. doi: 10.1016/j.canrad.2014.11.002. Epub 2015 Jan 16.

PMID:
25600666
14.

(18)F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer.

Levy A, Leboulleux S, Lepoutre-Lussey C, Baudin E, Ghuzlan AA, Hartl D, Deutsch E, Deandreis D, Lumbroso J, Tao Y, Schlumberger M, Blanchard P.

Oral Oncol. 2015 Apr;51(4):370-5. doi: 10.1016/j.oraloncology.2014.12.014. Epub 2015 Jan 13.

PMID:
25595614
15.

Processing shotgun proteomics data on the Amazon cloud with the trans-proteomic pipeline.

Slagel J, Mendoza L, Shteynberg D, Deutsch EW, Moritz RL.

Mol Cell Proteomics. 2015 Feb;14(2):399-404. doi: 10.1074/mcp.O114.043380. Epub 2014 Nov 23.

PMID:
25418363
16.

Focal or combined modality for the management of brain metastasis: did high tech radiotherapy superseded drug-radiotherapy combination?

Deutsch E, Dhermain F, Chargari C.

Ann Oncol. 2014 Dec;25(12):2293-4. doi: 10.1093/annonc/mdu477. Epub 2014 Oct 14. No abstract available.

PMID:
25316258
17.

Functional data analysis in NTCP modeling: a new method to explore the radiation dose-volume effects.

Benadjaoud MA, Blanchard P, Schwartz B, Champoudry J, Bouaita R, Lefkopoulos D, Deutsch E, Diallo I, Cardot H, de Vathaire F.

Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):654-63. doi: 10.1016/j.ijrobp.2014.07.008. Epub 2014 Sep 26.

PMID:
25304951
18.

Meeting new challenges: The 2014 HUPO-PSI/COSMOS Workshop: 13-15 April 2014, Frankfurt, Germany.

Orchard S, Albar JP, Binz PA, Kettner C, Jones AR, Salek RM, Vizcaino JA, Deutsch EW, Hermjakob H.

Proteomics. 2014 Nov;14(21-22):2363-8. doi: 10.1002/pmic.201470164. Epub 2014 Oct 9.

PMID:
25297050
19.

Improving safety in radiotherapy: the implementation of the Global Risk Analysis method.

Mazeron R, Aguini N, Rivin E, Baudré A, Bour MS, Dumas I, Hubert F, Lopes S, Desroches A, Deutsch E, Lefkopoulos D, Bourhis J.

Radiother Oncol. 2014 Aug;112(2):205-11. doi: 10.1016/j.radonc.2014.08.037. Epub 2014 Sep 19.

PMID:
25245555
20.

Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer.

Loriot Y, Mordant P, Dugue D, Geneste O, Gombos A, Opolon P, Guegan J, Perfettini JL, Pierre A, Berthier LK, Kroemer G, Soria JC, Depil S, Deutsch E.

Cell Death Dis. 2014 Sep 18;5:e1423. doi: 10.1038/cddis.2014.365.

PMID:
25232677
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk